Illumina (ILMN) News Today: Latest Market and Industry Updates

267.93
3.7700
1.39 %
Daily range
Weekly range
  • Dmytro Kharkov
  • 06.10.2026
ILMN slides nearly 6% as overbought conditions and debt refinancing weigh on sentiment
Illumina, Inc. (ILMN) fell 5.71% today after opening with an upside gap, as investors responded to recent quarterly revenue gains and clinical adoption news. The sharp pullback contradicts the ...
  • Parshwa Turakhiya
  • 05.10.2026
Why is Illumina stock up 5.3% today?
Illumina, Inc. (ILMN) surged 5.32% today as technical momentum and bullish buying pressure powered shares higher. This advance is supported by the stock’s strong position above short-, medium-, ...
  • Oleksii Zaichenko
  • 24.09.2026
Grail wins FDA panel backing for cancer blood test despite efficacy concerns
Regulatory scrutiny is intensifying for multi-cancer early detection tools as Grail moves closer to a U.S. approval decision for its blood-based screening test. An FDA advisory panel backs the ...
  • Hanna Syniavska
  • 17.09.2026
Illumina shares extend rally as earnings recovery supports biotech outperformance
Illumina is continuing to climb even as broader market sentiment remains focused on interest rates, AI and uneven biotech performance. The advance follows a long period of regulatory setbacks, ...
  • Igor Krasulya
  • 16.09.2026
What's behind Illumina's latest 3.3% stock surge?
Illumina, Inc. (ILMN) surged 3.26% today as renewed optimism followed its re-inclusion in the S&P 500 and confirmation of sustained earnings growth. The move is supported by strong upward ...
  • Ciaran Ryan
  • 21.08.2026
Why is Illumina stock up 3.1% today?
Illumina, Inc. (ILMN) surged 3.19% after new institutional buying and an upbeat Q2 revenue report fueled investor demand. The advance is reinforced by the stock trading firmly above all key moving ...
  • Andreas Kristo
  • 19.08.2026
Why is Illumina stock up 7.1% today?
Illumina, Inc. (ILMN) surged 7.16% after issuing $300 million in new notes, boosting its liquidity as investors react positively to a fresh funding round. The bullish structure is reinforced by ...
  • Andreas Kristo
  • 09.07.2026
Illumina stock rises nearly 4% as earnings beat forecasts and bullish momentum builds
Illumina, Inc. (ILMN) rose 3.68% after reporting stronger-than-expected quarterly revenue and raising full-year earnings guidance, driving renewed buying interest. The move is supported by the ...
  • Ashutosh Sureka
  • 01.07.2026
Illumina stock drops 2.51% as upside meets heavy resistance near $178.01
Illumina (ILMN) stock is trading at $176.56 after a daily drop of 2.51%. The price finished near session lows, now below its short-term moving averages but above ...
  • Emilio Ghigini
  • 30.06.2026
Selling pressure pushes Illumina stock lower in today's trading
Illumina, Inc. (ILMN) dropped 2.04% after Roche launched a new next-generation gene sequencing machine aimed at competing with Illumina's market position. The move faces limits, with bullish ...